India's Dr Reddy's inks distribution agreement with Takeda for dengue vaccine in India
18/09/2026 04:38
India's Dr Reddy's inks distribution agreement with Takeda for dengue vaccine in India Sept 18 (Reuters) - Dr Reddy's Laboratories REDY.NS said on Friday it signed a deal with Takeda Pharmaceutical Company 4502.T for the promotion and distribution of the Qdenga dengue vaccine in India.
(Reporting by Kashish Tandon in Bengaluru; Editing by Sonia Cheema)
((Kashish.Tandon@thomsonreuters.com; 8800437922;))
Recent news on Takeda Pharmaceutical
See all newsFactbox: Pharma sector doubles down on AI to slash costs, timelines
Nvidia-backed Iambic Therapeutics tumbles below IPO price
Factbox: Pharma sector doubles down on AI to slash costs, timelines
Factbox: Pharma sector doubles down on AI to slash costs, timelines
Nvidia-backed Iambic Therapeutics launches IPO as biotechs buck market gloom (updated)